Skip to main content
Clinical Trials/NL-OMON45948
NL-OMON45948
Recruiting
Not Applicable

Biomarkers in ALlergic diseases and allergen Immunotherapy - BALI

Franciscus Ziekenhuis0 sites160 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Franciscus Ziekenhuis
Enrollment
160
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Franciscus Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • 1\. Positive Skin Prick Test (SPT) response of \>\= 8 mm wheal diameter and/or serum allergen\-specific IgE levels higher than 0\.70 kU/L to grass pollen, tree pollen and/or house dust mite (HDM) extract.
  • 2\. Minimum of 18 years of age and a confirmed clinical diagnosis of allergic rhinitis.
  • 3\. Clinical indication for AIT.
  • 4\. Signed and dated informed consent (IC) form by a legally competent participant.

Exclusion Criteria

  • 1\. History of chronic autoimmune disease (aside from asthma, atopic dermatitis or allergic rhinitis) which may interfere with results.
  • 2\. Use of an antihistamines or decongestant therapy 7 days prior to screening visit.
  • 3\. Prior exposure to any monoclonal antibody treatment within the past 12 months.
  • 4\. Contraindication to sublingual or subcutaneous AIT.
  • 5\. Current immunosuppressive treatment.
  • 6\. Current pregnancy or breastfeeding, active pregnancy wish.
  • 7\. Previous immunotherapy with grass pollen, tree pollen or house dust mite extract.

Outcomes

Primary Outcomes

Not specified

Similar Trials